Coronavirus (COVID-19), CBER-Regulated Biologics

This page and the associated links provide information on guidance and advice relevant to the development of therapies to treat or prevent COVID-19, and contact information for developers seeking additional information or assistance.

Elsevier – Clinical Overviews │ Coronavirus │ COVID-19

PDF) Burden and Impact of Reactogenicity among Adults Receiving

Elsevier – Clinical Overviews │ Coronavirus │ COVID-19

Pharmaceutics, Free Full-Text

Special Feature: US FDA's Coronavirus Treatment Acceleration

Mechanisms and research advances in mRNA antibody drug-mediated

PDF) Impacts of a COVID-19 Educational Video: Evaluation of the

New COVID-19 Vaccines Will Keep Pharmacy Staff Busy

PDF) COVID-19 Vaccines: Where Did We Stand at the End of 2023?

The effects of the Covid-19 vaccine on menstrual disorders in

Vaccines, Free Full-Text

How Does the COVID-19 Vaccine Affect Life Insurance?

Advances in COVID-19 mRNA vaccine development

Mechanisms and research advances in mRNA antibody drug-mediated

Clinical Overview: 2023-2024 COVID-19 Vaccines